- Home
- MNPR vs MPX Comparison
MNPR vs MPX Comparison
Compare MNPR & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- MPX
- Stock Information
- Founded
- MNPR 2014
- MPX 1965
- Country
- MNPR United States
- MPX United States
- Employees
- MNPR N/A
- MPX N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- MPX Marine Transportation
- Sector
- MNPR Health Care
- MPX Industrials
- Exchange
- MNPR Nasdaq
- MPX Nasdaq
- Market Cap
- MNPR 248.8M
- MPX 297.8M
- IPO Year
- MNPR 2019
- MPX N/A
- Fundamental
- Price
- MNPR $34.98
- MPX $8.84
- Analyst Decision
- MNPR Strong Buy
- MPX Hold
- Analyst Count
- MNPR 7
- MPX 1
- Target Price
- MNPR $62.00
- MPX $8.00
- AVG Volume (30 Days)
- MNPR 20.7K
- MPX 20.1K
- Earning Date
- MNPR 08-12-2025
- MPX 07-24-2025
- Dividend Yield
- MNPR N/A
- MPX 6.32%
- EPS Growth
- MNPR N/A
- MPX N/A
- EPS
- MNPR N/A
- MPX 0.40
- Revenue
- MNPR N/A
- MPX $224,368,000.00
- Revenue This Year
- MNPR N/A
- MPX $3.97
- Revenue Next Year
- MNPR N/A
- MPX $13.02
- P/E Ratio
- MNPR N/A
- MPX $22.16
- Revenue Growth
- MNPR N/A
- MPX N/A
- 52 Week Low
- MNPR $2.15
- MPX $7.49
- 52 Week High
- MNPR $54.30
- MPX $10.32
- Technical
- Relative Strength Index (RSI)
- MNPR 43.89
- MPX 54.80
- Support Level
- MNPR $30.51
- MPX $8.20
- Resistance Level
- MNPR $36.51
- MPX $9.15
- Average True Range (ATR)
- MNPR 3.26
- MPX 0.29
- MACD
- MNPR -0.78
- MPX 0.04
- Stochastic Oscillator
- MNPR 37.87
- MPX 70.10
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.